BL
CLB icon

Balentine LLC’s Core Laboratories CLB Stock Holding History

Balentine LLC’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,245
Closed -$617K – 628
2019
Q3 		$617K Buy
13,245
+1,224
+10% +$56.9K 0.04% 49
2019
Q2 		$628K Buy
12,021
+3,033
+34% +$178K 0.04% 51
2019
Q1 		$620K Buy
+8,988
New +$603K 0.04% 49
2018
Q4 		– Sell
-59
Closed -$7K – 441
2018
Q3 		$7K Buy
+59
New +$6.66K ﹤0.01% 218
2018
Q1 		– Sell
-5,785
Closed -$634K – 148
2017
Q4 		$634K Buy
5,785
+481
+9% +$48K 0.05% 49
2017
Q3 		$524K Buy
5,304
+38
+0.7% +$3.68K 0.04% 51
2017
Q2 		$533K Buy
5,266
+347
+7% +$37.4K 0.05% 47
2017
Q1 		$568K Buy
4,919
+5
+0.1% +$581 0.06% 38
2016
Q4 		$590K Buy
4,914
+370
+8% +$41K 0.06% 31
2016
Q3 		$510K Buy
4,544
+3,651
+409% +$421K 0.07% 36
2016
Q2 		$111K Buy
893
+274
+44% +$33.1K 0.02% 104
2016
Q1 		$70K Hold
619
– – 0.02% 97
2015
Q4 		$67K Sell
619
-165
-21% -$18.9K 0.01% 139
2015
Q3 		$78K Hold
784
– – 0.01% 119
2015
Q2 		$89K Sell
784
-465
-37% -$56.4K 0.01% 101
2015
Q1 		$131K Buy
+1,249
New +$133K 0.02% 76

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Balentine LLC's CLB Position: Q4 2019 in Review

Balentine LLC sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 13,245 shares — an estimated $617K sold.

Balentine LLC first reported a position in CLB in Q1 2015 and held it in 16 quarters. The position peaked at $634K in Q4 2017. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • Balentine LLC reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
  • Balentine LLC sold 13,245 Core Laboratories shares in Q4 2019, an estimated $617K.
  • Balentine LLC first reported a position in Core Laboratories in Q1 2015 and held it in 16 quarters.
  • Balentine LLC's Core Laboratories position peaked at $634K in Q4 2017.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Balentine LLC's 13F filing for Q4 2019, filed 2 Sep 2020.